|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
CS233665B1
(en)
|
1983-01-06 |
1985-03-14 |
Antonin Holy |
Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
US6448392B1
(en)
|
1985-03-06 |
2002-09-10 |
Chimerix, Inc. |
Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
|
|
CS263952B1
(en)
|
1985-04-25 |
1989-05-12 |
Holy Antonin |
Remedy with antiviral effect
|
|
CS263951B1
(en)
|
1985-04-25 |
1989-05-12 |
Antonin Holy |
9-(phosponylmethoxyalkyl)adenines and method of their preparation
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
CS263955B1
(cs)
|
1986-07-18 |
1989-05-12 |
Holy Antonin |
Způsob výroby N-(3-hydroxy-2-fosfonylmethoxypropyl)derivátů heterocyklických bází
|
|
CS263956B1
(cs)
|
1986-07-18 |
1989-05-12 |
Holy Antonin |
Způsob výroby 9- (S) -, (3-hydroxy-2-fosfonylmetboxypropyl) adeninu
|
|
CS263953B1
(cs)
|
1986-07-18 |
1989-05-12 |
Holy Antonin |
Způsob výroby 9-(S)- nebo 9-(RS)-(3 hydroxy-2-íosfonylmethoxypropyl)- ads-ninu
|
|
CS264222B1
(en)
|
1986-07-18 |
1989-06-13 |
Holy Antonin |
N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
|
|
DE3778626D1
(de)
|
1986-09-27 |
1992-06-04 |
Toyo Jozo Kk |
Nukleosid-phospholipid-konjugat.
|
|
US5650510A
(en)
|
1986-11-18 |
1997-07-22 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
|
|
AU613592B2
(en)
*
|
1986-11-18 |
1991-08-08 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives
|
|
GB8724252D0
(en)
|
1987-10-15 |
1987-11-18 |
Ici Plc |
Fungicides
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US6599887B2
(en)
|
1988-07-07 |
2003-07-29 |
Chimerix, Inc. |
Methods of treating viral infections using antiviral liponucleotides
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
US5033352A
(en)
|
1989-01-19 |
1991-07-23 |
Yamaha Corporation |
Electronic musical instrument with frequency modulation
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5688778A
(en)
|
1989-05-15 |
1997-11-18 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Nucleoside analogs
|
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
SK280313B6
(sk)
|
1990-04-24 |
1999-11-08 |
�Stav Organick� Chemie A Biochemie Av �R |
N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
CA2085354C
(en)
|
1990-06-15 |
2002-08-27 |
Claude Piantadosi |
Ether lipid-nucleoside covalent conjugates
|
|
DE4026265A1
(de)
|
1990-08-20 |
1992-02-27 |
Boehringer Mannheim Gmbh |
Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
|
|
DE10399025I2
(de)
|
1990-09-14 |
2007-11-08 |
Acad Of Science Czech Republic |
Wirkstoffvorläufer von Phosphonaten
|
|
WO1992007065A1
(en)
|
1990-10-12 |
1992-04-30 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Modified ribozymes
|
|
DK0495421T3
(da)
|
1991-01-15 |
1996-12-09 |
Alcon Lab Inc |
Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
GB9126209D0
(en)
|
1991-12-10 |
1992-02-12 |
Orion Yhtymae Oy |
Drug formulations for parenteral use
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5652094A
(en)
|
1992-01-31 |
1997-07-29 |
University Of Montreal |
Nucleozymes
|
|
GB9205917D0
(en)
|
1992-03-18 |
1992-04-29 |
Smithkline Beecham Plc |
Pharmaceuticals
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US5532225A
(en)
|
1992-07-31 |
1996-07-02 |
Sri International |
Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods
|
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
|
US6005107A
(en)
|
1992-12-23 |
1999-12-21 |
Biochem Pharma, Inc. |
Antiviral compounds
|
|
US6444656B1
(en)
|
1992-12-23 |
2002-09-03 |
Biochem Pharma, Inc. |
Antiviral phosphonate nucleotides
|
|
GB9226879D0
(en)
|
1992-12-23 |
1993-02-17 |
Iaf Biochem Int |
Anti-viral compounds
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US5817647A
(en)
|
1993-04-01 |
1998-10-06 |
Merrell Pharmaceuticals Inc. |
Unsaturated acetylene phosphonate derivatives of purines
|
|
EP0632048B1
(en)
|
1993-06-29 |
2001-03-21 |
Mitsubishi Chemical Corporation |
Phosphonate-nucleotide ester derivatives
|
|
CA2171868A1
(en)
|
1993-09-17 |
1995-03-23 |
Petr Alexander |
Method for dosing therapeutic compounds
|
|
US5656745A
(en)
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
DE4418690A1
(de)
|
1994-05-28 |
1996-01-11 |
Boehringer Mannheim Gmbh |
Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
|
|
DE59506763D1
(de)
|
1994-06-29 |
1999-10-14 |
Ciba Sc Holding Ag |
Neue Kristallmodifikation eines Diketopyrrolopyrrolpigments
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
|
US7517858B1
(en)
|
1995-06-07 |
2009-04-14 |
The Regents Of The University Of California |
Prodrugs of pharmaceuticals with improved bioavailability
|
|
EP0832896A4
(en)
|
1995-06-15 |
1998-11-25 |
Mitsubishi Chem Corp |
NUCLEOTIDES DERIVED FROM PHOSPHONATES
|
|
US5717095A
(en)
|
1995-12-29 |
1998-02-10 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
CA2195262C
(en)
|
1996-01-18 |
2005-08-09 |
Masaru Ubasawa |
Phosphonate nucleotide compounds
|
|
US5877166A
(en)
|
1996-04-29 |
1999-03-02 |
Sri International |
Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
|
|
US6686462B2
(en)
|
1997-02-28 |
2004-02-03 |
The Regents Of The University Of California |
Antiviral compounds and methods of administration
|
|
AU6473098A
(en)
|
1997-03-24 |
1998-10-20 |
Eli Lilly And Company |
Difluoronucleoside phosphonic acids and derivatives thereof
|
|
ES2324746T3
(es)
|
1997-12-17 |
2009-08-13 |
Biocryst Pharmaceuticals Inc. |
Compuestos de ciclopentano y ciclopenteno sustituidos utiles como inhibidores de neuraminidasa.
|
|
US6350458B1
(en)
|
1998-02-10 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Mixed micellar drug deliver system and method of preparation
|
|
US6455571B1
(en)
|
1998-04-23 |
2002-09-24 |
Abbott Laboratories |
Inhibitors of neuraminidases
|
|
WO1999062921A1
(en)
|
1998-06-01 |
1999-12-09 |
S & T Science And Technology Inc. |
Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine
|
|
WO2000029414A1
(fr)
|
1998-11-18 |
2000-05-25 |
Viktor Veniaminovich Tets |
Dialkyl-1-aryl-1-(2,4-dioxo-5-amino-1,3-pyrimidin-5-yl)methylphosphonates
|
|
US7026469B2
(en)
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
|
EP1233770B1
(en)
|
1999-12-03 |
2008-02-13 |
The Regents of The University of California at San Diego |
Phosphonate compounds
|
|
CN1426418A
(zh)
|
2000-02-29 |
2003-06-25 |
三菱制药株式会社 |
膦酸酯核苷酸化合物
|
|
NZ536942A
(en)
|
2000-07-21 |
2006-03-31 |
Gilead Sciences Inc |
Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
|
|
MY141789A
(en)
|
2001-01-19 |
2010-06-30 |
Lg Chem Investment Ltd |
Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
|
|
CZ292199B6
(cs)
|
2001-03-08 |
2003-08-13 |
Ústav organické chemie a biochemie AV ČR |
O-Fosfonomethylcholin a jeho alkylestery, způsob jejich přípravy a použití
|
|
RU2187509C1
(ru)
|
2001-03-26 |
2002-08-20 |
Закрытое акционерное общество "Производственно-коммерческая Ассоциация АЗТ" |
Производные 5'-h-фосфоната 3'-азидо-3'-дезокситимидина и фармацевтические композиции на их основе
|
|
KR20020097384A
(ko)
|
2001-06-20 |
2002-12-31 |
미쯔비시 도꾜 세이야꾸 가부시끼가이샤 |
기존의 약제에 내성변이를 가지는 바이러스에 유효한 약제
|
|
MXPA04000138A
(es)
|
2001-06-29 |
2005-06-06 |
Acad Of Science Czech Republic |
Compuestos novedosos y metodos de trabajo.
|
|
US20040023928A1
(en)
|
2001-10-31 |
2004-02-05 |
Colacino Joseph Matthew |
Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox
|
|
CN1617877A
(zh)
|
2001-12-07 |
2005-05-18 |
三菱制药株式会社 |
膦酸酯核苷酸类似物在治疗乙肝病毒感染方面的用途
|
|
JP4942915B2
(ja)
|
2002-04-26 |
2012-05-30 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｉｖプロテアーゼ阻害剤化合物のホスホネートアナログの細胞蓄積
|
|
US7247621B2
(en)
|
2002-04-30 |
2007-07-24 |
Valeant Research & Development |
Antiviral phosphonate compounds and methods therefor
|
|
WO2003099294A1
(fr)
|
2002-05-24 |
2003-12-04 |
Mitsubishi Pharma Corporation |
Medicaments a selectivite tissulaire amelioree
|
|
PT1628685E
(pt)
|
2003-04-25 |
2011-03-16 |
Gilead Sciences Inc |
Análogos de fosfonatos antivirais
|
|
WO2004096235A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
WO2004111064A1
(en)
|
2003-06-16 |
2004-12-23 |
Institute Of Organic Chemistry And Biochemistry, Academy Of Sciences Of The Czech Republic |
Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
|
|
RS51476B
(sr)
*
|
2003-12-30 |
2011-04-30 |
Gilead Sciences, Inc. |
Fosfonati, monofosfonamidati, bisfosfonamidati za lečenje virusnih oboljenja
|
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
|
ES2523147T3
(es)
|
2004-02-26 |
2014-11-21 |
Baylor Research Institute |
Composiciones y métodos para el tratamiento sistémico de la artritis
|
|
WO2005087788A2
(en)
|
2004-03-04 |
2005-09-22 |
The Regents Of The University Of California |
Methods for preparation of nucleoside phosphonate esters
|
|
WO2006076015A2
(en)
|
2004-04-30 |
2006-07-20 |
The Regents Of The University Of California |
1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof
|
|
WO2006066074A2
(en)
*
|
2004-12-16 |
2006-06-22 |
The Regents Of The University Of California |
Lung-targeted drugs
|
|
CA2533721C
(en)
|
2005-01-25 |
2014-09-23 |
Dirtt Environmental Solutions Ltd. |
Method for wrapping a non-porous substrate object with a wood veneer
|
|
WO2006110656A2
(en)
|
2005-04-08 |
2006-10-19 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of viral infections and other medical disorders
|
|
CA2606399A1
(en)
|
2005-04-25 |
2006-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Scienc Es Of The Czech Republic |
Use of compounds to enhance processivity of telomerase
|
|
WO2007002808A1
(en)
|
2005-06-29 |
2007-01-04 |
Gilead Sciences, Inc. |
Anti-nonmelanoma carcinoma compounds, compositions, and methods of use thereof
|
|
WO2007002912A2
(en)
|
2005-06-29 |
2007-01-04 |
Gilead Sciences, Inc. |
Anti-proliferative compounds, compositions, and methods of use thereof
|
|
US7449612B2
(en)
|
2006-04-11 |
2008-11-11 |
Catalytic Distillation Technologies |
Paraffin alkylation process
|
|
EP2012799B1
(en)
|
2006-05-03 |
2016-08-24 |
Chimerix, Inc. |
Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
|
|
CN101089004A
(zh)
|
2006-06-13 |
2007-12-19 |
上海舒盟化学科技有限公司 |
一种新型的膦酸酯－核苷酸化合物
|
|
EP2144921A2
(en)
|
2007-02-27 |
2010-01-20 |
K.U. Leuven Research and Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
|
CN102702260A
(zh)
|
2007-04-27 |
2012-10-03 |
奇默里克斯公司 |
在核苷给药的受体中降低肾中毒性的方法
|
|
ES2572631T3
(es)
|
2008-01-25 |
2016-06-01 |
Chimerix, Inc. |
Métodos de tratamiento de infecciones virales
|
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
|
EP2284210B1
(en)
|
2008-04-30 |
2017-12-06 |
The University of Tokyo |
Charge conversional ternary polyplex
|
|
BRPI1005401A2
(pt)
|
2009-02-06 |
2019-04-02 |
Rfs Pharma, Llc |
pro-farmácos de purina nucleosídeo monofosfato para o tratamento de câncer e infecções virais
|
|
DE102009020261A1
(de)
|
2009-05-07 |
2010-11-11 |
Universität Hamburg |
Verfahren zur festphasengestützten Herstellung phosphatverbrückter Nucleosid-Konjugate
|
|
TW201107342A
(en)
|
2009-05-20 |
2011-03-01 |
Chimerix Inc |
Compounds, compositions and methods for treating viral infection
|
|
WO2011011519A1
(en)
|
2009-07-21 |
2011-01-27 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
|
WO2011011710A1
(en)
|
2009-07-24 |
2011-01-27 |
Chimerix, Inc. |
Methods of treating viral infections
|
|
JP2013501056A
(ja)
|
2009-08-03 |
2013-01-10 |
キメリクス，インコーポレイテッド |
ウイルス感染およびウイルス誘発腫瘍を治療する組成物および方法
|
|
EP2493479A4
(en)
*
|
2009-10-30 |
2013-04-17 |
Chimerix Inc |
METHOD FOR THE TREATMENT OF VIRUS DISEASES
|
|
PL2534150T3
(pl)
|
2010-02-12 |
2017-09-29 |
Chimerix, Inc. |
Sposoby leczenia infekcji wirusowej
|
|
US20110218241A1
(en)
|
2010-03-06 |
2011-09-08 |
Cacao Bio-Technologies, Llc |
Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
|
|
AU2011239560B2
(en)
|
2010-04-14 |
2016-11-03 |
The Regents Of The University Of California |
Phosphonates with reduced toxicity for treatment of viral infections
|
|
US8569321B2
(en)
|
2010-08-31 |
2013-10-29 |
Chimerix, Inc. |
Phosphonate ester derivatives and methods of synthesis thereof
|
|
US9156874B2
(en)
|
2011-01-03 |
2015-10-13 |
Nanjing Molecular Research, Inc. |
Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
|
|
CN103403014B
(zh)
|
2011-01-03 |
2016-07-06 |
河南美泰宝生物制药有限公司 |
O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途
|
|
KR101612642B1
(ko)
|
2011-08-16 |
2016-04-14 |
길리애드 사이언시즈, 인코포레이티드 |
테노포비어 알라펜아미드 헤미푸마레이트
|
|
JP5998229B2
(ja)
*
|
2011-12-08 |
2016-09-28 |
ビロベック・インコーポレイテッドＶｉｒｏｖｅｋ，Ｉｎｃ． |
毒性遺伝子を保有するベクター、そのための方法および使用
|
|
CN102532199B
(zh)
|
2012-02-29 |
2015-08-05 |
刘沛 |
核苷类化合物之新型苄基胺基磷酸酯前药的结构与合成
|
|
CN107056838A
(zh)
*
|
2013-03-15 |
2017-08-18 |
加利福尼亚大学董事会 |
无环核苷膦酸二酯
|
|
CN103435672A
(zh)
|
2013-04-25 |
2013-12-11 |
刘沛 |
含有取代苄基的新型核苷磷酸酯前药的结构与合成
|
|
DK2999476T3
(en)
|
2013-11-15 |
2018-09-03 |
Chimerix Inc |
MORPHIC FORMS OF HEXADECYLOXYPROPYL PHOSPHONATE TESTERS
|
|
KR102589658B1
(ko)
|
2014-09-15 |
2023-10-13 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
뉴클레오타이드 유사체
|
|
CN106188192B
(zh)
|
2015-04-29 |
2019-09-10 |
刘沛 |
含d-氨基酸酯的核苷氨基磷酸/膦酸酯衍生物及其医药用途
|
|
GB201509431D0
(en)
|
2015-06-01 |
2015-07-15 |
Equigerminal Sa |
Antiviral composition
|
|
US10377782B2
(en)
|
2015-09-15 |
2019-08-13 |
The Regents Of The University Of California |
Nucleotide analogs
|
|
CN107286190A
(zh)
|
2016-04-13 |
2017-10-24 |
刘沛 |
核苷之烃氧基苄基氨基磷酸/膦酸酯衍生物的制备及其医药用途
|
|
CN108602842B
(zh)
|
2016-11-02 |
2020-10-09 |
四川科伦博泰生物医药股份有限公司 |
杂环化合物及其制备方法和用途
|
|
CN108276444A
(zh)
|
2017-01-06 |
2018-07-13 |
米文君 |
一类新的化合物及其用途
|
|
JP2025526212A
(ja)
|
2022-07-21 |
2025-08-13 |
アンティバ バイオサイエンシズ インコーポレイテッド |
Ｈｐｖ感染症及びｈｐｖ誘発性新生物の治療用の組成物及び剤形
|